Research and Clinical Trials | Magna Wave PEMF

PEMF Research and Clinical Trials

PEMF Studies from around the world

We at Magna Wave want to welcome you to the world of PEMF: Pulsed Electromagnetic Field. PEMF is widely used in Eastern Europe and other parts of Europe, where it has been a standard therapy. While this is a new technology in North America, it is an innovative, emerging technology, with an already extensive research base behind it. Follow the link below to review the work that has been done in Europe and other countries to help you understand the opportunities in the use of (bio)magnetics and magnetic therapy. The PEMF modality is FDA cleared in the U.S. for nonunion fractures, incontinence, migraine headaches, Novocure for some forms of cancer and more. Three studies are currently underway with our PEMF devices for submission to the FDA for final clearance.

Pilot Study: Pulsed Electromagnetic Field Therapy (PEMFT) Alleviates Symptoms of Osteoarthritis

This study was designed to determine whether pulsed electromagnetic field therapy (PEMFT) could alleviate common symptoms of arthritis such as pain, swelling and immobility and whether it could contribute to overall wellbeing. Five volunteers, all of whom were diagnosed with osteoarthritis, participated in the study. Subjects treated themselves with the Centurion EZY system for 20 minutes, two to three times per week for four weeks. Subjects were tested for various physiological parameters including blood pressure, heart rate variability, balance of the autonomic nervous system (ANS), and stress at the beginning of the trial and at the end. An electro-interstitial scan was conducted to provide additional wellness parameters and a photograph was taken to document range of motion. Results were assessed on a case-by-case basis. PEMFT improved mobility in two of the cases after just one treatment and reduced pain and/or swelling in four of the five cases within 4 weeks. Additionally, general wellness related to cardiovascular health and balance of the ANS of participants improved throughout the course of the study. PEMF therapy may be a useful form of therapy to promote healing and to reduce symptoms of pain, swelling and immobility among patients with osteoarthritis. Furthermore, these treatments may have overall benefits to the health of the cardiovascular and the autonomic nervous system. Further testing needs to be done with a larger sample size to confirm these initial findings.

Doctor Robert Jay Rowan Talks About PEMF


How might that happen? A study showed that PEMF stimulated cultured fibroblasts to make more collagen! This will help strength and flexibility in tendons and ligaments. My chelation mentor Garry Gordon, DO, has told me of his incredible fixes of lame horses. The horses are so happy with the treatments, that when they see the therapist and machine approaching the fence, the animals come over on their own to get treated! That’s NOT placebo! If you suffer from diabetic neuropathy, I have good news. PEMF reduces pain and assists nerve repair in just a few weeks! So how does it work? Let’s start with the cell……

NASA On Stimulating Growth and Repair


For brevity we summarized the 33 page technical paper which we feel represents the essence of that communication. For those who wish to review the molecular and genetic portion of the report, refer to……

PEMF and Ozone in the Treatment of Osteoarthritis of the Knee

The protocol used with PEMF therapy for osteoarthritis of the knee was much higher than the application of NSAIDs with a statistically significant difference (p <0.5) and the results were even better when combined with intra-articular injections with ozone. In the groups treated with ozone and pulsed electromagnetic frequencies with no adverse events were reported, with the application of aines gastrointestinal adverse events and high blood pressure were presented.

Pulsed Electromagnetic Fields in the Treatment of Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH) is one of the most common diseases in men, and is a major health problem with very high economic costs. The etiology of this disease is multifactorial, and the actual factors associated with its development are age, prostate-specific antigen (PSA), and prostate volume.